
About Gopsi Pharma
Gopsi Pharma is a Healthcare company based in Pune (India) founded in 1997 by Baldev Prajapati. It manufactures pharmaceutical intermediates and derivatives for industrial use. It operates on a B2B model. Its Indian entity Gopsi Pharma Private Limited reported revenue of βΉ7.43 Cr. Gopsi Pharma offers products and services including Para Nitro Benzyl Bromide, Para Nitro Benzyl Alcohol, Para Cyano Benzyl Bromide, Para Bromo Benzyl Bromid, and Meta Cyano Benzyl Bromide. Its focus areas include Pharmaceuticals, Manufacturing and Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Gopsi Pharma Pvt. Ltd. is a manufacturer of pharmaceutical derivatives, specializing in active intermediates like Para Nitro Benzyl Bromide. Based in Bharuch, Gujarat, India, they operate under ISO 9001 certification, focusing on quality control and RD. The company produces a wide range of chemicals for pharmaceutical applications, ensuring compliance with standards and customer requirements through innovative practices and responsible waste management.
- Headquarters Pune, India
- Founders Baldev Prajapati
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website gopsipharma.net
- Legal Name Gopsi Pharma Private Limited
- Date of Incorporation 27 Jan, 1997
- Jurisdiction Ankleshwar, Gujarat, India
- Annual Revenue₹7.43 Cr
FY 2023 · +9% YoY
- Net Profit₹1.26 Cr
FY 2023 · 17% margin
- EBITDA₹1.85 Cr
FY 2023 · 25% margin
Associated legal entities of Gopsi Pharma
Gopsi Pharma operates through Gopsi Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Gopsi Pharma Private Limited CIN U24232GJ1997PTC031585 | Active | 27 Jan 1997 | Ankleshwar, Gujarat | ₹7.4 Cr | 3 | View details |
Products & Services of Gopsi Pharma
Gopsi Pharma offers a comprehensive portfolio of products and services, including Para Nitro Benzyl Bromide, Para Nitro Benzyl Alcohol, Para Cyano Benzyl Bromide, Para Bromo Benzyl Bromid, and Meta Cyano Benzyl Bromide.
Chemical used in drug synthesis for pharmaceutical production.
Intermediate compound for various drug manufacturing processes.
Essential chemical in synthesizing active pharmaceutical ingredients.
Compound applied in pharmaceutical derivative formulations.
Used as a building block in pharmaceutical chemical production.
Chemical for creating specialized pharmaceutical compounds.
Intermediate for advanced drug development applications.
Board of directors of Gopsi Pharma Private Limited (Gopsi Pharma)
Gopsi Pharma Private Limited is the primary company behind Gopsi Pharma. The board of Gopsi Pharma Private Limited currently have 3 directors; the longest-serving is Baldevbhai Govindbhai Prajapati, appointed in 1997. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Baldevbhai Govindbhai Prajapati DIN 01496198 | Director | 27 Jan 1997 | 29 yrs 9 mo | Gopsi Pharma Private Limited |
| Artiben Baldevbhai Prajapati DIN 07102109 | Director | 18 Feb 2015 | 11 yrs 9 mo | Gopsi Pharma Private Limited |
| Prajapati Vikasbhai Baldevbhai DIN 06587730 | Director | 18 Feb 2015 | 11 yrs 9 mo | Gopsi Pharma Private Limited |
People of Gopsi Pharma
1 people are tracked at Gopsi Pharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Baldev Prajapati | Founder, MD | Leadership |
Complete people profiles for Gopsi Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Gopsi Pharma
Figures of Gopsi Pharma Private Limited, the primary company behind Gopsi Pharma, for FY 2023. Revenue was ₹7.43 Cr (+9% year on year). Net profit was ₹1.26 Cr (17% margin). EBITDA was ₹1.85 Cr (25% margin). Revenue has grown at a compounded annual rate of -3% over three years and +30% over five years.
- ₹7.43 CrRevenue · FY 2023 · +9% YoY
- ₹1.26 CrNet profit · 17% margin
- ₹1.85 CrEBITDA · 25% margin
- ₹9.9 LakhPaid-up capital
- -3%Revenue CAGR, 3 years
- +30%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Gopsi Pharma Private Limited are on its company page.
Detailed financial statements for Gopsi Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Gopsi Pharma
Gopsi Pharma has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Gopsi Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Gopsi Pharma
Gopsi Pharma was founded in 1997.
Gopsi Pharma is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
The primary company behind Gopsi Pharma, Gopsi Pharma Private Limited, reported revenue of βΉ7.43 Cr for FY 2023, up 9% year on year.
Gopsi Pharma Pvt. Ltd. is a manufacturer of pharmaceutical derivatives, specializing in active intermediates like Para Nitro Benzyl Bromide. Based in Bharuch, Gujarat, India, they operate under ISO 9001 certification, focusing on quality control and RD. The company produces a wide range of chemicals for pharmaceutical applications, ensuring compliance with standards and customer requirements through innovative practices and responsible waste management.
Gopsi Pharma's top competitors include Laurus Labs, Symbiotec and SeQuent.
Gopsi Pharma offers Para Nitro Benzyl Bromide, Para Nitro Benzyl Alcohol, Para Cyano Benzyl Bromide, Para Bromo Benzyl Bromid, and 3 more products and services.
Gopsi Pharma operates through Gopsi Pharma Private Limited.
The legal entities of Gopsi Pharma currently have 3 directors, including Artiben Baldevbhai Prajapati, Prajapati Vikasbhai Baldevbhai, Baldevbhai Govindbhai Prajapati.